Status:

TERMINATED

Uqora Supplements in Women With UTIs

Lead Sponsor:

Hawthorne Effect Inc.

Collaborating Sponsors:

Uqora, Inc.

Conditions:

Urinary Tract Infections

Eligibility:

FEMALE

18+ years

Brief Summary

This is a virtual study which will invite females over the age of 18 who have had 2 or more UTIs in the past 6 months to participate. The investigators are looking at the impact of a daily dietary sup...

Detailed Description

Urinary Track Infections (UTIs) are the second most common infection in the United Stated. There is growing concern about the amount of antibiotic use and drug resistance. Patients with frequent UTIs ...

Eligibility Criteria

Inclusion

  • Is female
  • Is 18 years of age or older
  • Is able to swallow pills
  • Has been treated with antibiotics for 2 or more UTIs in the past 6 months
  • Is otherwise in good health Subjects will be deemed to be in good health if they do not report any of the existing medical conditions asked about in the screening questionnaire.

Exclusion

  • Has any of the following medical conditions: multiple sclerosis; diabetes; chronic kidney stones ○ Subjects with multiple sclerosis, diabetes, and/ or chronic kidney stones will be excluded from the study because these subjects are more likely to have complicated UTIs.
  • Uses a wheelchair ○ Subjects that use a wheelchair will be excluded from the study as these subjects are more likely to have complicated UTIs.
  • Regularly uses a catheter
  • ○ Subjects that use catheters will be excluded from the study as these subjects are more likely to have complicated UTIs.
  • Is pregnant
  • ○ Pregnant women and women that become pregnant will be excluded from the study because of an increased likelihood these subjects will drop out from the study on recommendation from their physicians or other healthcare provider.
  • Is currently taking Uqora brand products for UTI prevention
  • ○ Subjects will be asked if they are currently taking other products for UTI prevention. If the subject indicates she is currently taking a Uqora product, she will be excluded from the study. If the subject indicates she is taking additional products for prevention (not Uqora products), she will not be excluded from the study and she will be eligible to be enrolled and randomly assigned into 1 of the 3 groups.
  • Is currently taking antibiotics prophylactically for the purpose of UTI prevention ○ These subjects will be excluded from the study because they have been instructed by their physician or other healthcare provider to take antibiotics on an ongoing basis, which would have a significant impact on the recurrence of UTIs.

Key Trial Info

Start Date :

April 18 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 16 2020

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT04024046

Start Date

April 18 2019

End Date

September 16 2020

Last Update

September 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Uqora, Inc.

San Diego, California, United States, 92116